Research reveals bacteria’s dynamic defense duo against phage viruses

With a new CEO at the helm and its hema­to­log­i­cal pro­gram still un­der a clin­i­cal hold, Ful­crum Ther­a­peu­tics has signed a li­cens­ing and dis­cov­ery deal

An­oth­er ex­ec­u­tive is out at Il­lu­mi­na. The DNA se­quenc­ing com­pa­ny said ear­li­er this week that CFO Joy­deep Goswa­mi will ex­it and the po­si­tion will be tak­en